Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures

Having faced increased clinical treatment failures with dihydroartemisinin-piperaquine (DHA-PPQ), Cambodia swapped the first line artemisinin-based combination therapy (ACT) from DHA-PPQ to artesunate-mefloquine given that parasites resistant to piperaquine are susceptible to mefloquine. However, tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Erhunse, Nekpen, Sahal, Dinkar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2021
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572664/
https://www.ncbi.nlm.nih.gov/pubmed/34765267
http://dx.doi.org/10.1016/j.jpha.2020.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572664/
https://www.ncbi.nlm.nih.gov/pubmed/34765267
http://dx.doi.org/10.1016/j.jpha.2020.07.005

Ejemplares similares